The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria.

ABSTRACT:

Background

Pneumococcal disease contributes significantly to childhood morbidity and mortality and treatment is costly. Nigeria recently introduced the pneumococcal conjugate vaccine (PCV) to prevent pneumococcal disease. The aim of this study is to estimate health provider and household costs for the treatment of pneumococcal disease in children aged <5 years (U5s), and to assess the impact of these costs on household income.

Methods

We recruited U5s with clinical pneumonia, pneumococcal meningitis or pneumococcal septicaemia from a tertiary level hospital and a secondary level hospital in Kano, Nigeria. We obtained resource utilisation data from medical records to estimate costs of treatment to provider, and household expenses and income loss data from caregiver interviews

SUBMITTER: Adamu AL 

PROVIDER: S-EPMC8804652 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature